MerLion Pharmaceuticals GmbH
Infectious Disease Therapeutics

MerLion Pharmaceuticals GmbH: Risk & public record

MerLion Pharmaceuticals GmbH: 7 research papers in five years.

Data updated Nov 20, 2026 · Back to the company report

What the registers and the postings say about this employer.

Legal entity active
MerLion Pharmaceuticals GmbH
Not checked
Sanctions lists
OFAC SDN, EU consolidated · sanctionssearch.ofac.treas.gov ↗
No match
Phishing reports
OpenPhish, Phishing.Database · openphish.com ↗
None
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices

Public record

MerLion Pharmaceuticals GmbH: 7 research papers in five years.

Research outputpapers its people wrote, per OpenAlex
7papers in five years
1.2kcitations
Antibiotic Resistance in Bacteria
Medicine
14 papers
Bacterial Genetics and Biotechnology
Biochemistry, Genetics and Molecular Biology
13 papers
Antibiotics Pharmacokinetics and Efficacy
Medicine
13 papers
Antimicrobial Resistance in Staphylococcus
Medicine
12 papers
Microbial Natural Products and Biosynthesis
Immunology and Microbiology
8 papers
Each line links its register: the agency's page, the EU Transparency Register, the FEC, the USPTO, CourtListener.